7 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
BMO start Sarepta at overweight, sees significant uptake for Elevidys https://seekingalpha.com/news/4060874-bmo-start-sarepta-at-overweight-sees-significant-uptake-for-elevidys?source=feed_sector_healthcare Jan 31, 2024 - BMO has initiated coverage of Sarepta Therapeutics (SRPT) with a outperform rating, citing its leading position in the Duchenne muscular dystrophy market. Read more here.
BMO upgrades Genmab to outperform, cites diversification potential https://seekingalpha.com/news/4071279-bmo-upgrades-genmab-to-outperform-cites-diversification-potential?source=feed_sector_healthcare Feb 23, 2024 - BMO has upgraded Genmab (GMAB) to outperform, stating that it was “incrementally more confident” in the company’s ability to diversify its business longer term
BMO starts Korro at outperform, cites upcoming data for AATD drug https://seekingalpha.com/news/4072585-bmo-starts-korro-at-outperform-cites-upcoming-data-for-aatd-drug?source=feed_sector_healthcare Feb 27, 2024 - BMO initiated coverage of Korro Bio (KRRO) with an outperform rating, citing upcoming data for its AATD drug candidate KRRO-110 and potential partnerships. Read more here.
Eli Lilly takes early lead in weight loss drug race, BMO says https://seekingalpha.com/news/4051344-eli-lilly-takes-lead-weight-loss-drug-race-bmo?source=feed_sector_healthcare Dec 29, 2023 - Eli Lilly's (LLY) weight loss drug Zepbound is gaining market traction, challenging competitor Novo Nordisk (NVO). Read more here.
3 Incredibly Cheap High-Yield Bank Stocks to Buy Now https://www.fool.com/investing/2024/01/28/3-incredibly-cheap-high-yield-bank-stocks-to-buy/?source=iedfolrf0000001 Jan 28, 2024 - The yields on this trio of Canadian banks are near their highest levels of the past decade. The problems they face aren't that bad.
Jefferies, BMO bullish on newly public Metagenomi https://seekingalpha.com/news/4076822-jefferies-bmo-bullish-on-newly-public-metagenomi?source=feed_sector_healthcare Mar 06, 2024 - Jefferies and BMO have initiated coverage of newly public Metagenomi (MGX) with bullish ratings, citing the company’s wide array of gene editing tools. Read more here.
Bank of Montreal (BMO) Q4 2023 Earnings Call Transcript https://seekingalpha.com/article/4655450-bank-of-montreal-bmo-q4-2023-earnings-call-transcript?source=feed_sector_transcripts Dec 01, 2023 -

Pages: 1

Page 1